🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Apotex Health Corp. (TSX:APTX)
Canada flag Canada · Delayed Price · Currency is CAD
41.70
+0.53 (1.29%)
Nov 19, 2026, 4:00 PM EST

Apotex Health Statistics

Total Valuation

Apotex Health has a market cap or net worth of CAD 9.55 billion. The enterprise value is 12.41 billion.

Market Cap9.55B
Enterprise Value 12.41B

Important Dates

The last earnings date was Thursday, November 12, 2026.

Earnings Date Nov 12, 2026
Ex-Dividend Date Dec 14, 2026

Share Statistics

Apotex Health has 229.03 million shares outstanding. The number of shares has increased by 14.12% in one year.

Current Share Class 229.03M
Shares Outstanding 229.03M
Shares Change (YoY) +14.12%
Shares Change (QoQ) +21.40%
Owned by Insiders (%) 0.14%
Owned by Institutions (%) 10.32%
Float 228.71M

Valuation Ratios

PE Ratio n/a
Forward PE 18.61
PS Ratio 2.98
PB Ratio 22.13
P/TBV Ratio n/a
P/FCF Ratio 47.18
P/OCF Ratio 29.06
PEG Ratio 0.70
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.53, with an EV/FCF ratio of 61.32.

EV / Earnings n/a
EV / Sales 3.87
EV / EBITDA 15.53
EV / EBIT 19.94
EV / FCF 61.32

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 6.81.

Current Ratio 1.76
Quick Ratio 0.83
Debt / Equity 6.81
Debt / EBITDA 3.68
Debt / FCF 14.52
Interest Coverage 2.60

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) -2.04%
Return on Capital Employed (ROCE) 17.90%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 534,319
Profits Per Employee -1,561
Employee Count6,000
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Apotex Health has paid 98.72 million in taxes.

Income Tax 98.72M
Effective Tax Rate 110.48%

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 33.76
200-Day Moving Average n/a
Relative Strength Index (RSI) 81.86
Average Volume (20 Days) 429,033

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Apotex Health had revenue of CAD 3.21 billion and -9.37 million in losses. Loss per share was -0.07.

Revenue3.21B
Gross Profit 1.64B
Operating Income 622.60M
Pretax Income 89.35M
Net Income -9.37M
EBITDA 767.34M
EBIT 622.60M
Loss Per Share -0.07
Full Income Statement

Balance Sheet

The company has 77.96 million in cash and 2.94 billion in debt, with a net cash position of -2.86 billion or -12.49 per share.

Cash & Cash Equivalents 77.96M
Total Debt 2.94B
Net Cash -2.86B
Net Cash Per Share -12.49
Equity (Book Value) 431.47M
Book Value Per Share 1.88
Working Capital 933.56M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 328.60 million and capital expenditures -126.18 million, giving a free cash flow of 202.42 million.

Operating Cash Flow 328.60M
Capital Expenditures -126.18M
Depreciation & Amortization 144.74M
Net Borrowing -949.46M
Free Cash Flow 202.42M
FCF Per Share 0.88
Full Cash Flow Statement

Margins

Gross margin is 51.03%, with operating and profit margins of 19.42% and -0.29%.

Gross Margin 51.03%
Operating Margin 19.42%
Pretax Margin 2.79%
Profit Margin -0.29%
EBITDA Margin 23.94%
EBIT Margin 19.42%
FCF Margin 6.31%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.48%.

Dividend Per Share 0.20
Dividend Yield 0.48%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio 12.45%
Buyback Yield -14.12%
Shareholder Yield -13.64%
Earnings Yield -0.16%
FCF Yield 2.12%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Analyst Forecast

The average price target for Apotex Health is 44.13, which is 5.83% higher than the current price. The consensus rating is "Buy".

Price Target 44.13
Price Target Difference 5.83%
Analyst Consensus Buy
Analyst Count 14
Revenue Growth Forecast (3Y) 5.40%
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Apotex Health has an Altman Z-Score of 2.17 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.17
Piotroski F-Score 3